The self-administration of once-weekly dose s of 300 mg D a pso ne (DDS) by leprosy patients in lhe Mwanza region of Tanzania was monitored using the urine-test method described by Ellard er ai. (1974a). DDS/creatinine rat ios were determined on urine samples voided by 65 supervised le prosy patients on each of 7 successive days following the ingestion of 300 mg DDS. The method was then applied to urine sa mples collected by means of surprise visits to the homes of 158 out-patients 2 days after the day on which a 300 mg dose of DDS should have been taken. The extent of DDS self-ad ministration by the out-patienls was estimated by comparing the results with those obtained from controls given supervised DDS doses and from subjects not laking DDS. Significant amounts of DDS were not detected in the urine sa mples collected from 30% of the out-patienls. Furthermore the average DDS/creatinine ratios of lhe urine sa mples of the other out-patients were significantly lower than those from the supervised controls. The implications of these fi ndings to the treatment of leprosy in the Mwanza region and their relevance to olher leprosy conlrol schemes is discussed.
Introduction
The successful mass treatment of leprosy is largely dependent on the regularity with which out-patients take the DOS tablets they are given. Furthermore irregularity of DOS treatment is probably one of the main factors that promote the emergence of OOS-resistant strains of My co bacterium leprae (Rees, 1967 ; Jacobson, 1973) . The potential unreliability of daily self-medication of DOS has been demonstrated by Ellard and his co-workers who showed that only about a half of the prescribed DOS doses had been taken by patients in Malawi in the days immediately preceeding their attendance at the c\inic (Ellard et aI. , 197 4b). Similar irregularity in daily self-medication was fb und in Ethiopia by Low and Pearson (1974) . The effectiveness of cost1y programmes for the mass treatment of leprosy may therefore be substantially impaired if these fi ndings are typical of the situation in the world's m aj or endemic areas.
The quantitative determ ination of the ratio of DOS and its acid-Iabile metabolites to creatinine in the urine provides a simple and relatively sensitive method for monitoring DOS self-administratio n (Ellard et ai. , 1974a). However, 202 H. C. J. HUIKESI-lOVEN I:.T AL.
in contrast to lhe patients stuelieel in Malawi anel Ethiopia, most lcprosy patients in Ta nzania an; prescribcel wcekly doses of DOS fo r self-ad ministration.
This paper cl escribes an investigation of the applieability of Ellard's method to monito r the ingcst ion of weekly doses of DOS, and an examination of the actual regularity of el apsone self-administration in the Mwanza region of Tanzania.
Methods

COLLECTION OF URINE SAMPLES FROM CONTROLS AND OUT-PATIENTS
Contro /s. DOS urine samples were eolleeteel f Tom 18 a el u l t in-patients (10 male, 8 fe male ) fro m the leprosy warel of the h ospital at Sengere ma (Gci ta el istriet, Mwanza region) anel fro m 49 adult l e p rosy patients (23 male, 26 fe male) living in or aro u n el the lepro sy eontrol cen tre at Shirali (Tarime el istrict, Mara region). Thc Se nge re ma patients were uneler tre atment with weekly d oses of 300 mg DOS. Thc Shirati patien ts were treateel with 200 mg DOS weekly ptior to this stuely. In lhc last 2 weeks before urine was colleeteel all of these patients were treateel with 300 mg DOS once a week, ingesteel between 09.00 anel 10.00 hrs unelcr supervisiono Urine samplcs were eolleetcel between 08.30 anel I 1.00 h rs on t h e 7 el ays folIowing t he el ay on whieh the econel s uperv ise el el ose of 300 mg was takcn. Th e patients were askeel to empty their blad el e rs early in the morning prior to passing urine for the req uireel sa mple s. The next elose of DOS was given only after the last uri n e sa m ple was eolleeteel. Blank urine samples were also eollceteel from 67 st a ff, patients not under treatment with DOS an d visitors to the Se n ge re ma anel Shirati hospitaIs.
Out-patien ts. Urine sa m ple s ("fielel sam ples" ) wcre eolleetcel from 158 aelult out-pa t i e n ts (80 male, 78 fe male) l i v ing in se parate houses in the Mwanza anel Kwimba elistricts of the Mwanza region. Pat ients were se leeteel who hael attcndeel their monthly c1inie regularly aeeorel ing to the el e fini tion of the WHO Expert Committee on Leprosy ( 1970) . The patients were also seleeteel so as to p roviele a re p re se n tati ve samp le from both the small a n ell a rge c1 i nies t h roughout eaeh of th e 2 elistriets. Urine samp le s were e ollee te el fro m these patients b y me ans of surp ri se visits to their homes between 10.00 anel 16.00 hrs 2 elays after the elay on whieh the fo urth weekly self-aelministereel el ose of 300 mg DDS sh o uld have been taken. AlI urine sample s mentioned were eolleeteel by the a uthors th e mse lve s .
ANALYSES OF URINE SAMPLES.
Urine samples were eolleeteel by filling up a small eontainer eontaining an amount of 2N HCI eq uivalent to a thirel of i ts e apa e i t y . The hydroehlorie aeiel se rved both as a preservative aga inst baeterial growth anel a s an agent to hyel rolyse the aeiel-Iabile metabolites of DDS. Previously it had bee n foun d t h at s toring sueh aei el i fied uri ne samples at room t em pe ra t ure fo r I week did n ot affect the DDSjereat inine rati os signifie antly Ellarel et aI. . 197 4a ) . D u ring the p rese n t study however it was shown that storing urine samples at ambient t e mperat ures for several months i n fl u eneeel the estimations. Comparing aliquots of 31 urine samples storeel for 90 days at _ 20 0 C with a1iquots of the sa me sampl es storeel at room temperature (+25 0 C), the latter aliq uots showeel an average el eerease in measurable DDSjereatin ine ratios of 20%. In this stuel y urine samples were therfore estimated as soon as possible after eolleetion (ave rage delay: 5 d ays) ,. and only in exeeptio nal cases were stored for a few weeks at room temperature prior to analysis. DDSjereat i n ine ratios were d e te r m i n ed using the method eleseribeel by Ellard et alo (1974a). The resuIts from a fe w samples had to be diseareled beeause in the determination of acid-Iabile DDS, protein p recipita t i on occurred arter the addition of trich loroacetic acid (about 1 % of the samples) or because the presence of sulphonamid es was revea led (another 1 % of the samples) (Ellard et ai. , 1974b) .
Results
OOS/CREATININE RATIOS IN URINES FROM 65 SUPERVlSED PATlENTS, COMPAREO WITH BLANK VALUES FOUNO IN 62 CONTROL URINES
The val ues fo und in urines from supervised patients and controls are summarized in Table I . A distinction was made between the ratios found in urine samples from men and those fo und in urine samples from women. This is based on the well established fa ct that the daily excretion of creatinine by women is signi fi can tly less than that in men (Documen ta Geigy, 1970) . The results prese nte d in Table I full y justify this distinction and indicate : I. DDSjcreatinine ratios in urines collected on successive days a rte r the ingestion of 300 mg DDS fe ll re latively slowly . When the ratios were corrected fo r the mean blank values, the DDSjcreatinine ratios fe ll exponentially with an average half-life of 38 h in both men and women. 2. H igher ratios in urine samplcs from fc male p atients than in those fro m ma le patien ts.
Significant diffe rences between the mean blank values and the mean values of
DDSjcreatinine ratios in urines from patients taking 300 mg DDS, even on the seventh day arter ingestion of the dose . 4. Wide ranges of individual values within each group, so that as e arly as the third day after ingesti on of 300 mg DDS one result overlapped with those obtained from the blank urines. The ranges, mean values and 95% confidence limits of the means are illustrated in Fig. I .
DOS/C R EATINI NE RATIOS IN URINES FROM 158 OUT-PATIENTS COMPAREO WITH BLANK ANO CONTROL VALUES
On the basis of the data summarized in Table I urine samples from the out-patients were classified as " positive" or " negative" according to whether the DDS/creatinine ratios (iJ.g/ mg) were greater or less than 10.0 (men) or 12.0 (women), respectively. The results obtained when samples were classified in this way are compared in Table 2 with the blank and control values. They indicate that: I. About 30% or the urine samples were nega tive and among these samples the mean DDS/creatinine ratios were very similar to those of the blank urines. 2. The mean DDS/creatinine ratios of the positive urine samples were signifi cantly lower than those of the control samples taken 2 days after dosage with 300 mg DDS (P < 0.0005). The frequency distributions of the DDS/creatinine ratios are illustrated in Fig. 2 .
Discussion
The organization of the fi eld study was based on the results obtained from the supervised patients and controls. The easiest method of obtaining urine samples from the out-patients would have been to have collected them when the patients attended at the monthly clinic to collect their supply of DDS tablets for the fo llowing 4 weeks. However, because of the large overlap between the DDS/ creatinine ratios determined among supervised controls 7 days after dosage with 300 mg DDS and the values fo r untreated subjects (Table I, Fig. I ), fo r a high proportion of subjects it would have been impossible to judge with certainty from such urines whether or not the previous dose had been taken. Furthermore it was fo und that a number of the patients often did not come to the clinics themselves but sent a relative or neighbour to collect their DDS tablets for them. As a . urines trom women
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.. consequence the more laborious approach of coJlecting urine samples by means of home visits had to be fo llowed .
End-points for classifying urine samples as positive and negative had to be chosen so that they would misclassify the least numbers of genuinely positive and nega tive urine samples. The end-points chosen for men and women were 10 and 12 p.g DDS/mg creatinine, re spectively. If such criteria had been applied to the urine samples coJlected for up to 4 days from the controls given supervised 300 mg doses of DOS. only 2 of the 258 samples would have been considered as negative, and only I of the 62 blank urine samples would have b een cJassified as positive.
In this study it was decided to collect urine samples 2 days after the day on which a dose of 300 mg DOS should have been taken. Thus positive results would also have been anticipated fro m patients who had taken only 100 or 200 mg DOS instead of the fu ll 300 mg dose, or who had taken the correct dose a fe w days too early or one day late. However, it can be reasonably argued that adequate DOS blood leveIs were probably being achieved in most of those patients from whom urine samples were cJassified as being positive. Thus Ellard et aI. (1971) have shown that daily dosage with I mg DOS results in the maintenance of DOS blood leveis continously in excess of about 0.01 I1g/ml and prevents the multiplication of drug sensitive leprosy bacilli in the body. The levei of 0.0 I I1g/ml is considered to be the minimal inhibitory concentration. A dose of 300 mg DOS gives a mean blood leveI of more than 3 I1g/ml (Powell et aI. . 1967; Glazko et aI. , 1968) . In the present study the mean half-life of DOS determined among the 65 supervised patients was 38 ± 1.2 h for both men and women. This value is significantly higher than those of 21 h (Glazko et ai. , 1968), 28 h (Peters et aI. . 1974 (Peters et aI. . , 1975 , 29 h (Peters et aI. . 1972) and 31 h (Ellard et ai. . 1974b) reported from determinations of the rates of fali of DOS plasma concentrations. Although the higher DOS half-life determ ined in the present study was based on renal excretion, DOS blood leveis probably fali with the same half-Iife (Glazko e t ai. ,
1968).
It is therefore probable that in the average patient in the Mwanza region of Tanzania DOS blood leveis would take about 13 days to fali below the minimal inhibitory concentration against M. leprae after giving a 300 mg dose of the drug. Since the DDS/creatinine end-points chosen to discriminate between positive and negative urines were equivalent to the mean ratios in urines from supervised patients 7 days after the ingestion of 300 mg DOS ( Table I, Fig. I ), a positive result indicated that inhibitory DOS blood leveis would probably be maintained for at least another 6 days, that is until the next scheduled intake of DOS. Although these calculations are based on mean values, they provide a context from which the possible therapeutic relevance of these results may be discussed.
Similar considerations raise the possibility that a significant proportion of patients providing urine samples that were classified as nega tive might still have been taking therapeutically significant doses of DOS. However, the similarity between the mean DDS/creatinine ratios of the field urine samples cJassified as nega tive and the blank urine samples from the controls (Table 2) indicates that the majority of the nega tive urine samples were ' correctly graded. Although no attemp t was made in the present study to determine the consistency with which positive or negative urine test results would be given by individual patients, it is probable that the results obtained truly represe nt the overall picture of DOS self-administration among regularly attending out-patients in the Mwanza region of Tanzania. If then one keeps the necessary restrictions in mind, it may be said that also weekly self-medication of leprosy patients can be monitored by DDS/creatinine ratios in urines. Thus it may be concJuded fro m Table 2 that at any one time about 30% of the out-patients prescribed 300 mg DDS once-weekly are not taking their prescribed weekly doses of 300 mg DOS. The difference between men and women in this regard is not significant. It was also apparent that the mean values of the positive samples were significantly lower than the mean values of the ratios for control urines taken 2 days after a 300 mg DOS dose. These data may be compared with the results of the study of Ellard et aI. (1974b ) in Malawi among patients on a self-medication schedule of 25 mg DOS elaily. In the Malawi study 30% of the patients were fo und to take DOS grossly irregularly. The definitions given in the text are such that this group may be compared with the "neg à tive" groups (30%) in the present stuely. If one compares our "positive" groups with the rest of the Malawian results, again the results of the 2 studies agree re markably. The evaluation of the Malawian re sults in terms of the estima ted percentage of doses taken by ali out-patients (52-53%) may also be compared with a same evaluation of the present results in which about 50% of the doses we re taken. This last fi gure was confirmed by determining the DDSjcreatinine of pools of aliquots prepared from ali the urine samples. An exact comparison of our results with those fo und in E-t hiopia (Low and Pearson, 1974) is somewhat more elifficult, due to the diffe rent way in which the Ethiopian results were presented. Th e trend of irregularity however is evidently the same.
Carrying out analyses on re presenta tive pools of urine sa mples can red uce the cost of this type of st udy. On the other hand it also reduces the amount of informa tion gathered. Another way of reducing expenditure is to use the services of local medicaI helpers to collect the urine samples. This was tried in two other districts of the Mwanza region where 154 urine samples were collected by Health H ome Visitors. However, many difficulties were encountered, especially as regards communication and although the overall results did not diffe r significantly from those presented in Table 2 , the authors fe ar that too much uncertainty was associated with these collections. Nevertheless in some situations local helpers may be able to undertake a great part of the work.
Finally it should be emphasized that the actual situation regarding the regularity of DOS se lf-administration in the Mwanza region is probably more unfavourable than is suggested by our results. Of the estimated 13, 700 leprosy patients in the region only 43 12 are registered and of the latter only about 50% attend regularly fo r treatment. The sample in the present study was taken from this minority who attend regularly fo r treatment. Those patients who either do not attend at ali or who do not attend regularly are obviously not receiving effective treatment.
On the other hand the proportions of these groups of patients still req uiring treatment is not known. It is evident however that irregularity is one of the ma in fa ctors that promote the emergence of DDS-resistant strains of M. lep rae (Rees, 1967 ; Jacobson, 1973) . Although there are great differences between control schemes, the similarity between the results obtaii1ed in the present stuely anel those of studies conelucted in Malawi (ElIard et ai. , 1974b ) and Ethiopia (Low and Pearson, 1974) suggests that these fi ndings are probably applicable to many other similar schemes. This should be a cause for concern anel reflection. Methods of improving the regularity of both cJinic attendance and self-medication are cJearly required. If such methods cannot be fo und, the objectives of many current leprosy control schemes may be incapable of realisation.
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